[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial
[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE: Functional Precision Oncology for Metastatic Breast Cancer Feasibility Trial
Sponsor: University of Utah
Terminated
It was not feasible to perform FES PET/CT
Other terminated trials from University of Utah
Other Estrogen Receptor Positive Breast Cancer trials with similar outcome
A EARLY_PHASE1 clinical study on Estrogen Receptor Positive Breast Cancer, this trial is terminated or withdrawn. The trial is conducted by University of Utah and has accumulated 8 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Nov 2024 — Present [monthly]
Terminated EARLY_PHASE1
Status: Recruiting → Terminated
-
Sep 2024 — Nov 2024 [monthly]
Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting EARLY_PHASE1
-
Jun 2024 — Jul 2024 [monthly]
Recruiting EARLY_PHASE1
-
May 2023 — Jun 2024 [monthly]
Recruiting EARLY_PHASE1
▶ Show 3 earlier versions
-
May 2022 — May 2023 [monthly]
Recruiting EARLY_PHASE1
-
Jun 2021 — May 2022 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — Jun 2021 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Utah
For direct contact, visit the study record on ClinicalTrials.gov .